Last reviewed · How we verify
Standard Adjuvant Endocrine Therapy (standard-adjuvant-endocrine-therapy)
Standard Adjuvant Endocrine Therapy (generic name: standard-adjuvant-endocrine-therapy) is a drug developed by Pfizer Inc.. It is currently in Phase 3 development.
At a glance
| Generic name | standard-adjuvant-endocrine-therapy |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 3 |
Approved indications
Common side effects
- NAUSEA
- DIARRHOEA
- ALOPECIA
- FATIGUE
- CONSTIPATION
- ARTHRALGIA
- HEADACHE
- HOT FLUSH
- ANAEMIA
- NEUROPATHY PERIPHERAL
- EPISTAXIS
- COUGH
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard Adjuvant Endocrine Therapy CI brief — competitive landscape report
- Standard Adjuvant Endocrine Therapy updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Standard Adjuvant Endocrine Therapy
What is Standard Adjuvant Endocrine Therapy?
Standard Adjuvant Endocrine Therapy (standard-adjuvant-endocrine-therapy) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Standard Adjuvant Endocrine Therapy?
Standard Adjuvant Endocrine Therapy is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Standard Adjuvant Endocrine Therapy?
standard-adjuvant-endocrine-therapy is the generic (nonproprietary) name of Standard Adjuvant Endocrine Therapy.
What development phase is Standard Adjuvant Endocrine Therapy in?
Standard Adjuvant Endocrine Therapy is in Phase 3.
What are the side effects of Standard Adjuvant Endocrine Therapy?
Common side effects of Standard Adjuvant Endocrine Therapy include NAUSEA, DIARRHOEA, ALOPECIA, FATIGUE, CONSTIPATION, ARTHRALGIA.